Politico April 1, 2025
Drug and medical device makers didn’t oppose Robert F. Kennedy Jr.’s confirmation as health secretary but are speaking up in opposition to the agency downsizing he ordered.
Drugmakers made a calculated risk during HHS Secretary Robert F. Kennedy Jr.’s confirmation process in choosing not to publicly criticize a nominee who called their products dangerous.
They’re starting to reconsider.
After the firing of thousands of Department of Health and Human Services employees on Tuesday, industry trade groups that have mostly sought to curry favor with the new administration began to express alarm.
“While we support improving FDA efficiency to deliver more affordable generic and biosimilar medicines to patients faster, many of the reported cuts appear to do the opposite,” said John...
Today's Sponsors
Today's Sponsor